Not Your Average Skin Cancer: A Rare Case of Pilomatrix Carcinoma.
Pilomatrix carcinoma
malignant pilomatricoma
malignant pilomatrixoma
Journal
The Journal of clinical and aesthetic dermatology
ISSN: 1941-2789
Titre abrégé: J Clin Aesthet Dermatol
Pays: United States
ID NLM: 101518173
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
entrez:
5
9
2020
pubmed:
5
9
2020
medline:
5
9
2020
Statut:
ppublish
Résumé
Pilomatrix carcinoma is a rare malignancy stemming from aberrant proliferation of matrical cells found in developing hair. This neoplasm demonstrates a bimodal age distribution and a proclivity for developing on the head or neck. Clinically, a firm, painless, violaceous nodule with overlying ulceration is commonly described. Pilomatrix carcinoma is considered a variable-grade malignancy that tends to be locally aggressive, though metastatic disease occurs in 10 to 16 percent of cases. Mortality rates range from 7 to 9 percent. Although there is no definitive treatment protocol, surgical intervention in the form of local excision or via Mohs micrographic surgery can be considered, with radiotherapy adopted as an effective alternative for nonsurgical, recurrent, or metastatic disease. Here, we describe the case of a 62-year-old man who presented for evaluation of a red, enlarging lesion on his forehead which became tender and started to bleed shortly before the patient presented to our clinic. The patient was ultimately referred to a tertiary care center for surgical excision and, at the time of this pubilcation, has been tumor-free for more than one year. This case of a rare and often unconsidered neoplasm underscores the importance of clinical suspicion and close patient follow up to prevent local recurrence, metastasis, and death.
Types de publication
Case Reports
Langues
eng
Pagination
40-42Informations de copyright
Copyright © 2020. Matrix Medical Communications. All rights reserved.
Déclaration de conflit d'intérêts
FUNDING:No funding was provided for this study. DISCLOSURES:The authors have no conflicts of interest relevant to the content of this article.
Références
Mol Clin Oncol. 2017 Mar;6(3):415-418
pubmed: 28451423
J Cutan Pathol. 2014 May;41(5):427-36
pubmed: 24673383
Am J Dermatopathol. 2013 May;35(3):389-94
pubmed: 23221469
J Cutan Pathol. 2017 Jan;44(1):1-4
pubmed: 28000246
Am J Dermatopathol. 2017 Mar;39(3):e41-e43
pubmed: 27673386
J Cutan Med Surg. 2012 Sep-Oct;16(5):341-3
pubmed: 22971309
Br J Dermatol. 2004 Mar;150(3):511-6
pubmed: 15030335
Am J Dermatopathol. 2001 Oct;23(5):394-401
pubmed: 11801770
J Dermatol. 2010 Aug;37(8):735-9
pubmed: 20649718
J Am Acad Dermatol. 2014 Jul;71(1):38-43.e2
pubmed: 24739254
J Cutan Pathol. 2004 Apr;31(4):330-5
pubmed: 15005691
Ear Nose Throat J. 2016 Mar;95(3):117-20
pubmed: 26991221
Rare Tumors. 2010 Sep 30;2(3):e43
pubmed: 21139959
Dermatol Surg. 2011 Dec;37(12):1798-805
pubmed: 22093235
J Cutan Pathol. 2018 Jan;45(1):33-38
pubmed: 28914451
J Cutan Pathol. 2005 Feb;32(2):148-57
pubmed: 15606674
Dermatol Surg. 2007 Mar;33(3):333-9
pubmed: 17338692